The effect of baicalein on Wnt/ß-catenin pathway and miR-25 expression in Saos-2 osteosarcoma cell line

Background/aim: Osteosarcoma is the most common primary bone malignancy that occurs frequently in children and adolescents. Baicalein, a flavonoid that has attracted great attention in recent years with its strong antitumor activity, shows a wide range of biological and pharmaceutical effects.MicroRNAs have been found to be involved in many critical processes in cancers. This study aimed to investigate the effect of baicalein and miR-25 on Wnt/ß-catenin signaling pathway of osteosarcoma cell line Saos-2. Materials and methods: Cell viability was assessed, and qRT-PCR and Western blot were performed to study the effects of baicalein on expression of Wnt/ß-catenin signaling pathway-realted genes ß-catenin, GSK-3ß, and Axin2 of Saos-2 cells. Results: Our results indicated that baicalein can inhibit the proliferation IC50 value 35 -M , regulate Wnt/ß-catenin pathway and also increase miR-25 expression of Saos-2. Baicalein and also miR-25 decreased the expression of ß-catenin and Axin2, while increasing the expression of GSK-3ß. Down regulation of miR-25 decreased the expression of GSK-3ß, while ß-catenin and Axin2 expression increased. Conclusion: These findings demonstrate that baicalein may target genes related to the Wnt/ß-catenin pathway by regulating miR-25 expression and may be a potential Wnt/ß-catenin pathway inhibitor for osteosarcoma therapy.

Keywords:

MicroRNA, miR-25, baicalein, osteosarcoma Wnt/ß-catenin pathway, gene expression,

___

1. Broadhead ML, Clark JCM, Myers D, Dass CR, Choong PFM. The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011; 1-12. doi: 10.1155/2011/959248
2. Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: potential Wnt/β-catenin signaling modulators in cancer. Life Sciences 2011; 89: 545-554. doi: 10.1016/j. lfs.2011.05.003
3. Park S, Choi J. Inhibition of β-catenin/Tcf signaling by flavonoids. Journal of Cellular Biochemistry 2010; 110: 1376- 1385. doi: 10.1002/jcb.22654
4. Chen J, Li Z, Chen AY, Ye X, Luo H et al. Inhibitory effect of baicalin and baicalein on ovarian cancer cells. International Journal of Molecular Sciences 2013; 14 (3): 6012-6025. doi: 10.3390/ijms14036012
5. Ye F, Wang H, Zhang L, Zou Y, Han H et al. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROSinduced BNIP3 expression. Tumor Biology 2015; 36: 4731- 4740. doi: 10.1007/s13277-015-3122-y
6. Guo Z, Hu X, Xing Z, Xing R, Lv R et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/ AKT/mTOR pathway. Molecular and Cellular Biochemistry 2015; 406: 111-119. doi: 10.1007/s11010-015-2429-8
7. Li HL, Zhang S, Wang Y, Liang RR, Li J et al. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells. Molecular Medicine Reports 2013; 7: 266-270. doi: 10.3892/mmr.2012.1123
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297. doi: 10.1016/s0092- 8674(04)00045-5
9. Miao J, Wu S, Peng Z, Tania M, Zhang C. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumor Biology 2013; 34: 2093-2098. doi: 10.1007/s13277-013-0940-7
10. Kumar RMR, Boro A, Fuchs B. Involvement and clinical aspects of MicroRNA in osteosarcoma. International Journal of Molecular Sciences 2016; 17: 877. doi: 10.3390/ijms17060877
11. Xu Z, Li C, Qu H, Li H, Gu Q et al. MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway. Tumour Biology 2017; 39 (6): 1010428317711324. doi: 10.1177/1010428317711324
12. Li H, Zhang K, Liu LH, Ouyang Y, Guo HB et al. MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncology Letters 2015; 10: 1662-1668. doi: 10.3892/ol.2015.3378
13. Zhu S, Pan W, Qian Y. MicroRNA in immunity and autoimmunity. Journal of Molecular Medicine 2013; 91: 1039- 1050. doi: 10.1007/s00109-013-1043-z
14. Bian S. and Sun T. Functions of noncoding RNAs in neural development and neurological diseases. Molecular Neurobiology 2011; 44 (3): 359-373. doi: 10.1007/s12035-011- 8211-3
15. Guo Y and Niu S.MiR-25 protects PC-12 cells from H2O2 mediated oxidative damage via WNT/β-catenin pathway. The Journal of Spinal Cord Medicine 2017; 12: 1-10. doi: 10.1080/10790268.2017.1336319
16. Kocyigit I, Taheri S, Sener EF, Eroglu E, Ozturk F et al. Serum micro-RNA profiles in patients with autosomal dominant polycystic kidney disease according to hypertension and renal function. BMC Nephrology 2017; 18: 179. doi: 10.1186/s12882- 017-0600-z
17. Huo J, Zhang Y, Li R, Wang Y, Wu J et al.Upregulated MicroRNA-25 mediates the migration of melanoma cells by targeting DKK3 through the WNT/β-Catenin pathway. International Journal of Molecular Sciences 2016; 17: 1124. doi: 10.3390/ijms17111124
18. Li Q, ZouC, Zou C, Han Z, Xiao H et al. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Letters 2013; 335: 168-174. doi: 10.1016/j.canlet.2013.02.029
19. Kim YK, Yu J, Han TS, Park SY, Namkoong B et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Research 2009; 37: 1672-1681. doi: 10.1093/nar/gkp002
20. Poliseno L, Salmena L, Riccardi L, Fornari A, SongMS et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Science Signaling 2010; 3 (117): ra29. doi: 10.1126/scisignal.2000594
21. Feng X, Jiang J, Shi S, Xie H, Zhou L et al. Knockdown of miR25 increases the sensitivity of liver cancer stem cells to TRAILinduced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. International Journal of Oncology 2016; 49: 2600-2610. doi: 10.3892/ijo.2016.3751
22. He N, Zhang Z. Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway. Molecular and Cellular Biochemistry 2015; 405: 187-196. doi: 10.1007/s11010-015-2410-6
23. Liu B, Li G, Wang X, Liu Y. A furin inhibitor downregulates osteosarcoma cell migration by downregulating the expression levels of MT1 MMP via the Wnt signaling pathway. Oncology Letters 2014; 7: 1033-1038. doi: 10.3892/ol.2014.1839
24. Leichter AL, Sullivan MJ, Eccles MR, Chatterjee A. MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Molecular Cancer 2017; 16: 15. doi: 10.1186/s12943-017-0584-0
25. Anton R, Chatterjee SS, Simundza J, Cowin P, Dasgupta R. A systematic screen for Micro-RNAs regulating the canonical Wnt pathway. PLoS One 2011; 6 (10): e26257. doi: 10.1371/ journal.pone.0026257
26. Ma Y, Zhu B, Liu X, Yu H, Yong L et al. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway. Journal of Experimental & Clinical Cancer Research 2015; 34: 115. doi: 10.1186/s13046-015-0232-8
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) method. Methods 2001; 25 (4): 402-408. doi: 10.1006/meth.2001.1262
28. Han Z, Zhu S, Han X, Wang Z, Wu S et al. Baicalein inhibits hepatocellular carcinoma cells through suppressing the expression of CD24. International Immunopharmacology 2015; 29: 416-422. doi: 10.1016/j.intimp.2015.10.021
29. Liu X, Liu S, Chen J, He L, Meng X et al. Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling. Annals of Hematology 2016; 95: 1787-1793. doi: 10.1007/s00277-016-2766-z
30. Vega OA, Lucero CMJ, Araya HF, Jerez S, Tapia JC et al. Wnt/ β-catenin signaling activates expression of the bone-related transcription factor RUNX2 in select human osteosarcoma cell types. Journal of Cellular Biochemistry 2017; 118: 3662-3674. doi: 10.1002/jcb.26011
31. Haydon RC, Deyrup A, Ishikawa A, Heck R, Jiang W et al.Cytoplasmic and/or nuclear accumulation of the β-catenin protein is a frequent event in human osteosarcoma. International Journal of Cancer 2002; 102: 338-342. doi: 10.1002/ijc.10719
32. Huang K, Zhang J, Han L, You Y, Jiang T et al. MicroRNA roles in beta-catenin pathway. Molecular Cancer 2010; 9: 252-263. doi: 10.1186/1476-4598-9-252
33. Stolz A, Bastians H. Fresh WNT into the regulation of mitosis. Cell Cycle 2015; 14: 2566-2570. doi: 10.1080/15384101.2015.1064569
34. Taketo MM. Shutting down Wnt signal-activated cancer. Nature Genetics 2004; 36: 320-322. doi: 10.1038/ng0404-320
35. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Molecular and Cellular Biology 2002; 22: 1184-1193. doi: 10.1128/ mcb.22.4.1184-1193.2002
36. Onyido EK, Sweeney E, Nateri AS. Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches. Molecular Cancer 2016; 15: 56. doi: 10.1186/s12943-016-0541-3
37. Ma X, Yan W, Dai Z, Gao X, Ma Y et al. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Drug Design, Development and Therapy 2016;10: 1419-1441. doi: 10.2147/DDDT.S102541
38. Song JL, Nigam P, Tektas SS, Selva E. MicroRNA regulation of Wnt signaling pathways in development and disease. Cell Signalling 2015; 27: 1380-1391. doi: 10.1016/j.cellsig.2015.03.018
39. Suzuki A, Ozono K, Kubota T, Kondou H, Tachikawa K et al. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3β in osteoblastic Saos-2 Cells. Journal of Cellular Biochemistry 2008; 104: 304- 317. doi: 10.1002/jcb.21626
40. Yan K, Gao J, Yang T, Ma Q, Qiu X et al. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 2012; 7 (3): e33778. doi: 10.1371/ journal.pone.0033778